Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022
PHILADELPHIA, Nov. 02, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that it will host a virtual Research and Development (R&D) Day on Friday, November 11, 2022, from 8:00 AM to 9:30 AM ET.
Related news for (IPSC)
- Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
- Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
- Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
- Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
- Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
